Mind Medicine (MindMed) Inc. the people running the company have only been selling lately: three insiders unloaded about $561,000 of stock over 12 months, with no open-market purchases.
Selling on its own is common and often pre-planned (10b5-1 plans, taxes, diversification), so it matters more when it is unusually heavy or broad.
Quarter by quarter: No open-market insider buying or selling in the last full quarter. Insiders bought in 0 of the last 7 full quarters.
| Filed | Insider | Role | Type | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|---|
| Dec 29, 2025 | Karlin Daniel | Executive Officer | Sell | 5,600 | $13.15 | $74K | SEC |
| Dec 29, 2025 | Barrow Robert | CEO | Sell | 25,791 | $13.15 | $339K | SEC |
| Dec 29, 2025 | Sullivan Mark | Executive Officer | Sell | 11,276 | $13.15 | $148K | SEC |
| Sep 26, 2025 | Sullivan Mark | Executive Officer | Sell | 11,278 | $9.77 | $110K | SEC |
| Sep 26, 2025 | Barrow Robert | CEO | Sell | 25,797 | $9.77 | $252K | SEC |
| Sep 26, 2025 | Karlin Daniel | Executive Officer | Sell | 7,704 | $9.77 | $75K | SEC |
| Jun 26, 2025 | Sullivan Mark | Executive Officer | Sell | 11,491 | $6.80 | $78K | SEC |
| Jun 26, 2025 | Karlin Daniel | Executive Officer | Sell | 7,848 | $6.80 | $53K | SEC |
| Jun 26, 2025 | Barrow Robert | CEO | Sell | 26,491 | $6.80 | $180K | SEC |
| Mar 26, 2025 | Barrow Robert | CEO | Sell | 21,208 | $6.74 | $143K | SEC |
| Mar 26, 2025 | Karlin Daniel | Executive Officer | Sell | 6,836 | $6.74 | $46K | SEC |
| Mar 26, 2025 | Sullivan Mark | Executive Officer | Sell | 6,576 | $6.74 | $44K | SEC |
| Mar 26, 2025 | Liao Carrie | Executive Officer | Sell | 2,347 | $6.74 | $16K | SEC |
| Dec 27, 2024 | Liao Carrie | Executive Officer | Sell | 2,273 | $7.43 | $17K | SEC |
| Dec 27, 2024 | Karlin Dan | Executive Officer | Sell | 6,643 | $7.43 | $49K | SEC |
In the last 12 months Mind Medicine (MindMed) Inc. insiders made open-market purchases worth about $0 and sales worth about $561,000. Data comes from SEC Form 4 filings, updated every 30 minutes on CapitalSnitch.
The most recent open-market insider trade in MNMD was filed on 2025-12-29.
No congressional trades in MNMD were reported in the past two years. The full list is free on CapitalSnitch.
Public-record data for research and education, not investment advice. Insider sales are often pre-planned (10b5-1). Congress data: Data derived from public disclosures filed under the Ethics in Government Act and the STOCK Act, republished free for public transparency and news reporting. Disclosures may lag the trade by 45 days or more and show amounts only as ranges. This data may not be used for credit rating, loan underwriting, solicitation of money (political, charitable or other), direct-mail or commercial targeting (5 U.S.C. 13107).